Clinical Trials · NCT01732094
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Universitair Ziekenhuis Brussel
- Enrollment
- 57
- Start date
- Jul 2012
- Locations
- 1 site, Belgium
- Primary endpoint
- Ongoing pregnancy rate